Development and validation of a predictive model to identify patients at risk of severe COPD exacerbations using administrative claims data

por Annavarapu, Srinivas, Goldfarb, Seth, Gelb, Melissa, Moretz, Chad, Renda, Andrew, Kaila, Shuchita
Publicado 2018

Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD

por Moretz, Chad, Annavarapu, Srinivas, Luthra, Rakesh, Goldfarb, Seth, Renda, Andrew, Shaikh, Asif, Kaila, Shuchita
Publicado 2019

Incremental Costs Associated with Length of Hospitalization Due to Viral Pneumonia: Impact of Intensive Care and Economic Implications of Reducing the Length of Stay in the Era of...

por Wu, Ning, Kuznik, Andreas, Wang, Degang, Moretz, Chad, Xi, Ann, Kumar, Shambhavi, Hamilton, Laurie
Publicado 2020

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy

por Moretz, Chad, Hahn, Beth, White, John, Goolsby Hunter, Alyssa, Essoi, Breanna, Elliott, Caitlin, Ray, Riju
Publicado 2020

COPD exacerbation frequency and its association with health care resource utilization and costs

por Dhamane, Amol D, Moretz, Chad, Zhou, Yunping, Burslem, Kate, Saverno, Kim, Jain, Gagan, Renda, Andrew, Kaila, Shuchita
Publicado 2015

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs

por Schwab, Phil, Saundankar, Vishal, Bouchard, Jonathan, Wintfeld, Neil, Suehs, Brandon, Moretz, Chad, Allen, Elsie, DeLuzio, Antonio
Publicado 2016

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients

por Dhamane, Amol D, Schwab, Phil, Hopson, Sari, Moretz, Chad, Annavarapu, Srinivas, Burslem, Kate, Renda, Andrew, Kaila, Shuchita
Publicado 2016

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenanc...

por Moretz, Chad, Cole, Ashley L, Mu, George, Wu, Benjamin, Guisinger, Amy, Liu, Yunhao, Hahn, Beth, Baylis, Lee
Publicado 2020

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

por Schwab, Phil, Dhamane, Amol D, Hopson, Sari D, Moretz, Chad, Annavarapu, Srinivas, Burslem, Kate, Renda, Andrew, Kaila, Shuchita
Publicado 2017

Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pu...

por Slade, David, Ray, Riju, Moretz, Chad, Germain, Guillaume, Laliberté, François, Shen, Qin, Duh, Mei Sheng, Mahendran, Malena, Hahn, Beth
Publicado 2021

Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population...

por Ashcraft, Kristine, Grande, Kendra, Bristow, Sara L., Moyer, Nicolas, Schmidlen, Tara, Moretz, Chad, Wick, Jennifer A., Blaxall, Burns C.
Publicado 2022

Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retr...

por Moretz, Chad, Sharpsten, Lucie, Bengtson, Lindsay GS, Koep, Eleena, Le, Lisa, Tong, Junliang, Stanford, Richard H, Hahn, Beth, Ray, Riju
Publicado 2019

Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol

por Moretz, Chad, Bengtson, Lindsay GS, Sharpsten, Lucie, Koep, Eleena, Le, Lisa, Tong, Junliang, Stanford, Richard H, Hahn, Beth, Ray, Riju
Publicado 2019

Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease

por Slade, David, Ray, Riju, Moretz, Chad, Germain, Guillaume, Laliberté, François, Shen, Qin, Duh, Mei Sheng, MacKnight, Sean D., Hahn, Beth
Publicado 2021

Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population

por Sethi, Sanjay, Make, Barry J, Robinson, Scott B, Kumar, Shambhavi, Pollack, Michael, Moretz, Chad, Dreyfus, Jill, Xi, Ann, Powell, Dakota, Feigler, Norbert
Publicado 2022

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Co...

por Kalhan, Ravi, Slade, David, Ray, Riju, Moretz, Chad, Germain, Guillaume, Laliberté, François, Shen, Qin, Duh, Mei Sheng, MacKnight, Sean Dale, Hahn, Beth
Publicado 2021

Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations

por Fuoco, Morgan Justice, Mularski, Richard A, Wu, Benjamin, Moretz, Chad, McBurnie, Mary Ann, Stanford, Richard H, Crawford, Phillip, Gratie, Daniel, Salas, Bianca
Publicado 2021

Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database

por Moretz, Chad, Zhou, Yunping, Dhamane, Amol D., Burslem, Kate, Saverno, Kim, Jain, Gagan, Devercelli, Giovanna, Kaila, Shuchita, Ellis, Jeffrey J., Hernandez, Gemzel, Renda, Andrew
Publicado 2015

Healthcare utilization and costs for patients initiating Dabigatran or Warfarin

por Reynolds, Shannon L., Ghate, Sameer R., Sheer, Richard, Gandhi, Pranav K., Moretz, Chad, Wang, Cheng, Sander, Stephen, Costantino, Mary E., Annavarapu, Srinivas, Andrews, George
Publicado 2017

Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study

por Ashcraft, Kristine, Moretz, Chad, Schenning, Chantelle, Rojahn, Susan, Vines Tanudtanud, Kae, Magoncia, Gwyn Omar, Reyes, Justine, Marquez, Bernardo, Guo, Yinglong, Erdemir, Elif Tokar, Hall, Taryn O.
Publicado 2021